Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Medical Marijuana and Cannabidiol Research Expansion Act
View:
Post by blackspade799 on Mar 14, 2024 2:14pm

Medical Marijuana and Cannabidiol Research Expansion Act

The bill was introduced in the Senate February 4, 2021 by Senators Dianne Feinstein (D) of California, Brian Schatz (D) of Hawaii, and Chuck Grassley (R) of Iowa as S.253;[2][3] it was forwarded unanimously by the Senate Committee on the Judiciary and passed by Senate unanimously on March 24, 2022.[4] A new bill with minor changes was introduced in House on July 21, 2022, by four Republicans and two Democrats; Rep. Earl Blumenauer of Oregon was the lead sponsor.[5] It was passed by House under suspension of the rules 395-25 five days later.[6] On November 16, 2022, the Senate passed the House bill by voice vote and sent it to the President to be signed into law.[1][6] President Biden signed the bill into law on December 2, 2022.[7]

Provisions[edit]

The act requires the Drug Enforcement Administration to register researchers
and suppliers of cannabis for medical research in a timely manner, who will then
be able to legally manufacture, distribute, dispense and possess the substance.[8] 
It also creates a mechanism for FDA approval of drugs derived from the cannabis
plant and "[p]rotects doctors who may now discuss the harms and benefits of using
cannabis and cannabis derivatives."[9][a] It also requires the Department of Health
and Human Services to investigate the medical utility of cannabis and barriers that
exist to conducting research, and requires the Attorney General to conduct an
annual review to ensure that cannabis is being adequately produced for research
purposes

Comment by blackspade799 on Mar 18, 2024 7:47pm
So the American government passed a bill " Medical Marijuana and Cannabidiol Research Expansion Act" allowing Schools and companies the right to do R&D for Medical Cannabis But interested institutions have been stoped from starting any Medical Cannabis studies? People have been using Marijuana for 100's if no 1000s of years. Gradmas use it  for their arthritis, carpal ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities